Perigon Wealth Management LLC Raises Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)

Perigon Wealth Management LLC grew its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 34.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,697 shares of the company’s stock after buying an additional 10,355 shares during the period. Perigon Wealth Management LLC owned 0.07% of Health Catalyst worth $377,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in HCAT. Advisor Group Holdings Inc. lifted its position in shares of Health Catalyst by 86.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 5,324 shares of the company’s stock valued at $137,000 after buying an additional 2,467 shares during the last quarter. Fairfield Bush & CO. bought a new stake in shares of Health Catalyst during the 1st quarter valued at $25,000. Raymond James Financial Services Advisors Inc. raised its stake in shares of Health Catalyst by 118.6% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 11,157 shares of the company’s stock valued at $292,000 after purchasing an additional 6,053 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Health Catalyst by 4.9% during the 1st quarter. Bank of New York Mellon Corp now owns 750,396 shares of the company’s stock valued at $19,607,000 after purchasing an additional 35,022 shares during the period. Finally, US Bancorp DE raised its stake in shares of Health Catalyst by 14.0% during the 1st quarter. US Bancorp DE now owns 9,260 shares of the company’s stock valued at $242,000 after purchasing an additional 1,139 shares during the period. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Health Catalyst Price Performance

HCAT opened at $5.53 on Wednesday. The stock has a 50-day moving average price of $8.04 and a 200-day moving average price of $8.48. Health Catalyst, Inc. has a 12-month low of $5.51 and a 12-month high of $14.37. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $323.84 million, a P/E ratio of -2.63 and a beta of 1.29.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. The firm had revenue of $75.08 million during the quarter, compared to analysts’ expectations of $73.67 million. Equities analysts predict that Health Catalyst, Inc. will post -0.47 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCAT. Barclays began coverage on Health Catalyst in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $14.00 price objective on the stock. Guggenheim upgraded Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price objective on the stock in a research note on Friday, January 26th. Canaccord Genuity Group decreased their price objective on Health Catalyst from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Friday, February 23rd. KeyCorp reiterated a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Finally, Evercore ISI decreased their target price on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, Health Catalyst currently has a consensus rating of “Moderate Buy” and an average price target of $12.10.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.